Company news
Cannara Biotech, Inc. (TSX:LOVE) news
Every Cannara Biotech, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Cannara Establishes Automatic Share Purchase Plan
August 13, 2026
Cannara Announces Normal Course Issuer Bid
July 22, 2026
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Ex...
July 15, 2026
Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited
July 14, 2026
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
July 8, 2026
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand(TM) Live Rosin Infusion Technology
July 2, 2026
Cannara Completes Acquisition of Medican Organic Inc.
May 6, 2026
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec
April 14, 2026
Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026
April 7, 2026
Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange
March 19, 2026
Cannara Biotech Inc. (LOVE) Opens the Market
March 17, 2026
Cannara Announces Graduation to the Toronto Stock Exchange
February 26, 2026
Cannara to Host Investor Webcast on February 19th, 2026
February 12, 2026
Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share 
February 4, 2026
Cannara Announces Conditional Approval to List on the Toronto Stock Exchange
January 28, 2026
Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expans...
January 26, 2026
Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026
January 14, 2026
OTC Markets Group Welcomes Cannara Biotech Inc. to OTCQX
January 14, 2026
Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
January 2, 2026
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
November 24, 2025
Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update
November 17, 2025
Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity C...
October 7, 2025
Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance
October 2, 2025
Cannara Announces Grant of Options and RSUs
September 1, 2025
Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield
August 21, 2025
Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale
August 14, 2025
Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025
July 28, 2025
Cannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin Vapes
July 24, 2025
Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025
July 21, 2025
Cannara Biotech to Host Investor Webcast on June 25th, 2025
June 19, 2025
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
June 18, 2025
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
April 28, 2025
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
April 16, 2025
Cannara Biotech Reports Q2 2024 Financial Results
April 29, 2024
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans
February 8, 2024
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
January 30, 2024
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
January 8, 2024
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
December 13, 2023
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
December 11, 2023
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
December 7, 2023
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
July 27, 2023
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII
May 23, 2023
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
May 11, 2023
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
May 4, 2023
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
April 25, 2023
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
April 24, 2023
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan
February 28, 2023
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 C...
February 10, 2023
Cannara Biotech Inc. Reports Q1 2023 Financial Results
January 23, 2023
Cannara Announces Proposed Share Consolidation
January 12, 2023